Subjects
Adult male or female subjects in good general health were selected for enrollment in the study based on selection criteria and randomized to flubentylosin or placebo in Parts 1 and 3, and to fed or fasting conditions in Period 1 of Part 2.Key eligibility criteria included age between 18 and 55 years inclusive at the time of enrollment, body mass index ≥ 18.0 to ≤ 29.9 kg/m